- Home
- XNCR vs CAPL Comparison
XNCR vs CAPL Comparison
Compare XNCR & CAPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XNCR | CAPL |
|---|---|---|
| Founded | 1997 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 881.9M | 850.5M |
| IPO Year | 2013 | 2012 |
Fundamental Metrics
Financial Performance| Metric | XNCR | CAPL |
|---|---|---|
| Price | $11.87 | $21.60 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $22.33 | N/A |
| AVG Volume (30 Days) | ★ 648.0K | 50.2K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 9.96% |
| EPS Growth | 65.36 | ★ 96.15 |
| EPS | N/A | ★ 0.26 |
| Revenue | $125,576,000.00 | ★ $1,869,806,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.80 | $2.80 |
| P/E Ratio | ★ N/A | $85.08 |
| Revenue Growth | ★ 13.65 | N/A |
| 52 Week Low | $6.92 | $19.61 |
| 52 Week High | $18.69 | $23.34 |
Technical Indicators
Market Signals| Indicator | XNCR | CAPL |
|---|---|---|
| Relative Strength Index (RSI) | 49.68 | 44.76 |
| Support Level | $10.83 | $21.53 |
| Resistance Level | $12.87 | $23.08 |
| Average True Range (ATR) | 0.58 | 0.71 |
| MACD | 0.02 | -0.09 |
| Stochastic Oscillator | 49.60 | 6.04 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About CAPL CrossAmerica Partners
CrossAmerica Partners LP is engaged in the wholesale distribution of motor fuel and the ownership and leasing of real estate used in the retail distribution of motor fuel. The company operates through two business segments namely Wholesale and Retail. The Wholesale segment is a key revenue driver and includes the wholesale distribution of motor fuel to lessee dealers, independent dealers, commission agents, DMS, Circle K, and through company-operated retail sites. The Retail segment includes the sale of convenience merchandise items, the retail sale of motor fuel at company-operated retail sites, and the retail sale of motor fuel at retail sites operated by commission agents.